TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $235M (100.0% shares, 0.0% debt)

Holdings (22)

COGT Cogent Biosciences, Inc. 13.3%

Value $31.4M Shares 3,481,042 Share Price $9.02 * Est. Cost/Share $8.31 Unrealized @ Report Date -17.9%

— Iveric Bio, Inc. 11.9%

Value $28.04M Shares 2,914,250 Share Price $9.62 Est. Cost/Share $15.78 Unrealized @ Report Date —

GERN Geron Corporation 9.9%

Value $23.4M Shares 15,096,342 Share Price $1.55 * Est. Cost/Share $1.13 Unrealized @ Report Date +24.9%

KURA Kura Oncology, Inc. 9.1%

Value $21.4M Shares 1,167,642 Share Price $18.33 * Est. Cost/Share $14.41 Unrealized @ Report Date -0.2%

— CymaBay Therapeutics, Inc. 7.4%

Value $17.42M Shares 5,905,400 Share Price $2.95 Est. Cost/Share $3.38 Unrealized @ Report Date —

ACRS Aclaris Therapeuitics, Inc. 6.8%

Value $15.98M Shares 1,144,939 Share Price $13.96 Est. Cost/Share $15.07 Unrealized @ Report Date -7.0%

VRDN Viridian Therapeutics Inc 6.5%

Value $15.2M Shares 1,314,000 Share Price $11.57 * Est. Cost/Share $18.63 Unrealized @ Report Date -27.9%

— Chinook Therapeutics, Inc. 5.9%

Value $13.93M Shares 796,460 Share Price $17.49 Est. Cost/Share $16.31 Unrealized @ Report Date —

— Aerovate Therapeutics, Inc. 5.9%

Value $13.9M Shares 889,572 Share Price $15.63 Est. Cost/Share $12.06 Unrealized @ Report Date —

TRDA Entrada Therapeutics, Inc. 3.4%

Value $8.084M Shares 663,694 Share Price $12.18 Est. Cost/Share $17.12 Unrealized @ Report Date —

— Merus N.V. 2.9%

Value $6.792M Shares 300,000 Share Price $22.64 Est. Cost/Share $30.46 Unrealized @ Report Date —

TYRA Tyra Biosciences, Inc. 2.7%

Value $6.409M Shares 896,418 Share Price $7.15 * Est. Cost/Share $19.46 Unrealized @ Report Date -59.1%

— Akouos, Inc. 2.7%

Value $6.332M Shares 1,350,006 Share Price $4.69 Est. Cost/Share $7.65 Unrealized @ Report Date —

TNGX Tango Therapeutics, Inc. 2.3%

Value $5.31M Shares 1,172,250 Share Price $4.53 * Est. Cost/Share $8.67 Unrealized @ Report Date -30.1%

MLTX MoonLake Immunotherapeutics 2.2%

Value $5.25M Shares 1,000,000 Share Price $5.25 * Est. Cost/Share $6.29 Unrealized @ Report Date 0.0%

— Alpine Immune Sciences, Inc. 2.1%

Value $4.921M Shares 578,260 Share Price $8.51 Est. Cost/Share $13.85 Unrealized @ Report Date —

— 89bio, Inc. 1.6%

Value $3.649M Shares 1,133,196 Share Price $3.22 Est. Cost/Share $3.22 Unrealized @ Report Date —

ZLAB Zai Lab LTD-ADR 1.4%

Value $3.295M Shares 95,000 Share Price $34.68 Est. Cost/Share $62.85 Unrealized @ Report Date —

— Magenta Therapeutics, Inc. 1.1%

Value $2.549M Shares 2,124,122 Share Price $1.20 Est. Cost/Share $4.43 Unrealized @ Report Date —

ANAB AnaptysBio, Inc. 0.5%

Value $1.188M Shares 58,515 Share Price $20.30 * Est. Cost/Share $30.26 Unrealized @ Report Date -26.8%

— Elevation Oncology, Inc. 0.3%

Value $777K Shares 555,000 Share Price $1.40 Est. Cost/Share $6.02 Unrealized @ Report Date —

— Pardes Biosciences, Inc. 0.1%

Value $181K Shares 59,039 Share Price $3.07 Est. Cost/Share $7.22 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
COGT	Cogent Biosciences, Inc.	3,481,042	$31.4M	13.3%	$9.02 *	$8.31	-17.9%	COMMON STOCK	19240Q201
—	Iveric Bio, Inc.	2,914,250	$28.04M	11.9%	$9.62	$15.78	—	COMMON STOCK	46583P102
GERN	Geron Corporation	15,096,342	$23.4M	9.9%	$1.55 *	$1.13	+24.9%	COMMON STOCK	374163103
KURA	Kura Oncology, Inc.	1,167,642	$21.4M	9.1%	$18.33 *	$14.41	-0.2%	COMMON STOCK	50127T109
—	CymaBay Therapeutics, Inc.	5,905,400	$17.42M	7.4%	$2.95	$3.38	—	COMMON STOCK	23257D103
ACRS	Aclaris Therapeuitics, Inc.	1,144,939	$15.98M	6.8%	$13.96	$15.07	-7.0%	COMMON STOCK	00461U105
VRDN	Viridian Therapeutics Inc	1,314,000	$15.2M	6.5%	$11.57 *	$18.63	-27.9%	COMMON STOCK	92790C104
—	Chinook Therapeutics, Inc.	796,460	$13.93M	5.9%	$17.49	$16.31	—	COMMON STOCK	16961L106
—	Aerovate Therapeutics, Inc.	889,572	$13.9M	5.9%	$15.63	$12.06	—	COMMON STOCK	008064107
TRDA	Entrada Therapeutics, Inc.	663,694	$8.084M	3.4%	$12.18	$17.12	—	COMMON STOCK	29384C108
—	Merus N.V.	300,000	$6.792M	2.9%	$22.64	$30.46	—	COMMON STOCK	N5749R100
TYRA	Tyra Biosciences, Inc.	896,418	$6.409M	2.7%	$7.15 *	$19.46	-59.1%	COMMON STOCK	90240B106
—	Akouos, Inc.	1,350,006	$6.332M	2.7%	$4.69	$7.65	—	COMMON STOCK	00973J101
TNGX	Tango Therapeutics, Inc.	1,172,250	$5.31M	2.3%	$4.53 *	$8.67	-30.1%	COMMON STOCK	87583X109
MLTX	MoonLake Immunotherapeutics	1,000,000	$5.25M	2.2%	$5.25 *	$6.29	0.0%	COMMON STOCK	61559X104
—	Alpine Immune Sciences, Inc.	578,260	$4.921M	2.1%	$8.51	$13.85	—	COMMON STOCK	02083G100
—	89bio, Inc.	1,133,196	$3.649M	1.6%	$3.22	$3.22	—	COMMON STOCK	282559103
ZLAB	Zai Lab LTD-ADR	95,000	$3.295M	1.4%	$34.68	$62.85	—	COMMON STOCK	98887Q104
—	Magenta Therapeutics, Inc.	2,124,122	$2.549M	1.1%	$1.20	$4.43	—	COMMON STOCK	55910K108
ANAB	AnaptysBio, Inc.	58,515	$1.188M	0.5%	$20.30 *	$30.26	-26.8%	COMMON STOCK	032724106
—	Elevation Oncology, Inc.	555,000	$777K	0.3%	$1.40	$6.02	—	COMMON STOCK	28623U101
—	Pardes Biosciences, Inc.	59,039	$181K	0.1%	$3.07	$7.22	—	COMMON STOCK	69945Q105